Sinocelltech Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Sinocelltech Ltd.
RECRUITINGPhase 1 / Phase 2NCT06754605
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
This is a randomised, double-blind, placebo-controlled Phase 1/2 clinical trial to evaluate the safety, tolerability and immunogenicity of recombinant respiratory syncytial virus...
Sponsor: Sinocelltech Ltd.Enrolling: 4802 locations
Respiratory Syncytial Virus
RECRUITINGPhase 3NCT07437404
Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.
This is an Open Label, Uncontrolled Study to Evaluate the the Safety and Efficacy of SCT800 for Prophylaxis Treatment in Severe Previously Untreated Hemophilia Patients.
Sponsor: Sinocelltech Ltd.Enrolling: 361 location
Haemophilia A
RECRUITINGPhase 3NCT07388602
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and...
The purpose of this study is to evaluate the efficacy and safety of SCTC21C plus cyclophosphamide, bortezomib and dexamethasone (VCd) compared with VCd alone in treatment of newly...
Sponsor: Sinocelltech Ltd.Enrolling: 901 location
Amyloidosis